Company intelligence / Profile preview

BioResponse Nutrients

Lafayette, Colorado, United Statesbioresponsesolutions.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Microencapsulated Diindolylmethane (DIM) has demonstrated improved absorption over standard DIM and is supported by preclinical/human research on hormone metabolism and related health outcomes. Clinical studies have used this ingredient at multiple universities, supporting its safe use in managing estrogen metabolism.

Therapeutic areas: Endocrinology
Modalities: Small moleculeDietary ingredient (specifically Diindolylmethane/DIM)
Industry: Food & Nutrition

Partnerships

Companies worldwide via signed licensing agreements for proprietary ingredient supply

Beyond the preview

Go deeper on BioResponse Nutrients.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioResponse Nutrients.

Explore the full profile